Decision-making about complementary and alternative medicine by cancer patients: integrative literature review

Laura Weeks, Lynda G Balneaves, Charlotte Paterson, Marja Verhoef, Laura Weeks, Lynda G Balneaves, Charlotte Paterson, Marja Verhoef

Abstract

Background: Patients with cancer consistently report conflict and anxiety when making decisions about complementary and alternative medicine (CAM) treatment. To design evidence-informed decision-support strategies, a better understanding is needed of how the decision-making process unfolds for these patients during their experience with cancer. We undertook this study to review the research literature regarding CAM-related decision-making by patients with cancer within the context of treatment, survivorship, and palliation. We also aimed to summarize emergent concepts within a preliminary conceptual framework.

Methods: We conducted an integrative literature review, searching 12 electronic databases for articles published in English that described studies of the process, context, or outcomes of CAM-related decision-making. We summarized descriptive data using frequencies and used a descriptive constant comparative method to analyze statements about original qualitative results, with the goal of identifying distinct concepts pertaining to CAM-related decision-making by patients with cancer and the relationships among these concepts.

Results: Of 425 articles initially identified, 35 met our inclusion criteria. Seven unique concepts related to CAM and cancer decision-making emerged: decision-making phases, information-seeking and evaluation, decision-making roles, beliefs, contextual factors, decision-making outcomes, and the relationship between CAM and conventional medical decision-making. CAM decision-making begins with the diagnosis of cancer and encompasses 3 distinct phases (early, mid, and late), each marked by unique aims for CAM treatment and distinct patterns of information-seeking and evaluation. Phase transitions correspond to changes in health status or other milestones within the cancer trajectory. An emergent conceptual framework illustrating relationships among the 7 central concepts is presented.

Interpretation: CAM-related decision-making by patients with cancer occurs as a nonlinear, complex, dynamic process. The conceptual framework presented here identifies influential factors within that process, as well as patients' unique needs during different phases. The framework can guide the development and evaluation of theory-based decision-support programs that are responsive to patients' beliefs and preferences.

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Results of search strategy and process of identifying articles related to complementary and alternative medicine and decision-making by patients with cancer.
Figure 2
Figure 2
Conceptual framework of the decision-making process for complementary and alternative medicine (CAM) by patients with cancer. Conventional medical-decision making is included in this framework because making decisions about CAM cannot be separated from making decisions about conventional medicine. Social factors, cultural norms, and demographic and disease-related factors constitute the "contextual factors" discussed in the text. Transitions from one phase to another within the decision-making trajectory may occur at times of crisis or milestones, such as the end of conventional treatment and transition to survivorship or palliative care.

References

    1. Balneaves LG, Bottorff JL, Hislop TG, Herbert C. Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern Complement Med. 2006;12(5):459–466.
    1. Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R. A population- based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther. 2003;2(3):212–216.
    1. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655–663.
    1. Gansler T, Kaw C, Crammer C, Smith T. A population-based study of prevalence of complementary methods use by cancer survivors: a report from the American Cancer Society's studies of cancer survivors. Cancer. 2008;113(5):1048–1057.
    1. Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population- based study. J Cancer Surviv. 2011;5(1):8–17.
    1. Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005;4(2):187–194.
    1. Rayner L, Easthope G. Postmodern comsumption and alternative medications. J Sociol. 2001;37(2):157–176.
    1. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;(343):1–19.
    1. Deng G. Integrative cancer care in a US academic cancer centre: the Memorial Sloan–Kettering Experience. Curr Oncol. 2008;15(Suppl 2):s108.es68–s108.es71.
    1. Chong OT. An integrative approach to addressing clinical issues in complementary and alternative medicine in an outpatient oncology center. Clin J Oncol Nurs. 2006;10(1):83–88.
    1. Peace G, Manasse A. The Cavendish Centre for integrated cancer care: assessment of patients' needs and responses. Complement Ther Med. 2002;10(1):33–41.
    1. Balneaves LG, Truant TL, Kelly M, Verhoef MJ, Davison BJ. Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM) Support Care Cancer. 2007;15(8):973–983.
    1. Frenkel M, Cohen L. Effective communication about the use of complementary and integrative medicine in cancer care. J Altern Complement Med. 2014;20(1):12–18.
    1. Seely D, Oneschuk D. Interactions of natural health products with biomedical cancer treatments. Curr Oncol. 2008;15(Suppl 2):s109. es81–s10. es6.
    1. Williamson EM. Drug interactions between herbal and prescription medicines. Drug Saf. 2003;26(15):1075–1092.
    1. Juraskova I, Hegedus L, Butow P, Smith A, Schofield P. Discussing complementary therapy use with early-stage breast cancer patients: exploring the communication gap. Integr Cancer Ther. 2010;9(2):168–176.
    1. Markovic M, Manderson L, Wray N, Quinn M. Complementary medicine use by Australian women with gynaecological cancer. Psychooncology. 2006;15(3):209–220.
    1. Truant T, Bottorff JL. Decision making related to complementary therapies: a process of regaining control. Patient Educ Counsel. 1999;38(2):131–142.
    1. Verhoef MJ, White MA. Factors in making the decision to forgo conventional cancer treatment. Cancer Pract. 2002;10(4):201–207.
    1. Shumay DM, Maskarinec G, Kakai H, Gotay CC. Cancer Research Center of Hawaii. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract. 2001;50(12):1067–1067.
    1. Owens B. A test of the self-help model and use of complementary and alternative medicine among Hispanic women during treatment for breast cancer. Oncol Nurs Forum. 2007;34(4):E42–E50.
    1. Jones RA, Taylor AG, Bourguignon C, Steeves R, Fraser G, Lippert M, et al. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors. Oncol Nurs Forum. 2007;34(2):359–364.
    1. Torraco RJ. Writing integrative literature reviews: guidelines and examples. Human Resour Dev Rev. 2005;4(3):356–367.
    1. Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546–553.
    1. Balneaves LG, Kristjanson LJ, Tataryn D. Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns. 1999;38(2):143–153.
    1. Bishop FL, Yardley L. Constructing agency in treatment decisions: negotiating responsibility in cancer. Health (London) 2004;8(4):465–482.
    1. Boon H, Westlake K, Deber R, Moineddin R. Problem-solving and decision-making preferences: no difference between complementary and alternative medicine users and non-users. Complement Ther Med. 2005;13(3):213–216.
    1. Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003;62(5):849–853.
    1. Boon H, Brown JB, Gavin A, Kennard MA, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res. 1999;9(5):639–653.
    1. Brazier A, Cooke K, Moravan V. Using mixed methods for evaluating an integrative approach to cancer care: a case study. Integr Cancer Ther. 2008;7(1):5–17.
    1. Broom A. Intuition, subjectivity, and Le bricoleur: cancer patients' accounts of negotiating a plurality of therapeutic options. Qual Health Res. 2009;19(8):1050–1059.
    1. Broom A, Tovey P. Exploring the temporal dimension in cancer patients' experiences of nonbiomedical therapeutics. Qual Health Res. 2008;18(12):1650–1661.
    1. Broom A, Tovey P. The dialectical tension between individuation and depersonalization in cancer patients' mediation of complementary, alternative and biomedical cancer treatments. Sociology. 2007;41(6):1021–1039.
    1. Brown JB, Carroll J, Boon H, Marmoreo J. Women's decision-making about their health care: views over the life cycle. Patient Educ Couns. 2002;48(3):225–231.
    1. Chiu L, Balneaves LG, Barroetavena MC, Doll R, Leis A. Use of complementary and alternative medicine by Chinese individuals living with cancer in British Columbia. J Complement Integr Med. 2006;3(1) Article 2.
    1. Evans M, Shaw A, Thompson EA, Falk S, Turton P, Thompson T, et al. Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used. BMC Complement Altern Med. 2007;7:25–25.
    1. Evans MA, Shaw AR, Sharp DJ, Thompson EA, Falk S, Turton P, et al. Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care? Eur J Cancer Care. 2007;16(6):517–525.
    1. Gray RE, Greenberg M, Fitch M, Parry N, Douglas MS, Labrecque M. Perspectives of cancer survivors interested in unconventional therapies. J Psychosoc Oncol. 1998;15(3/4):149–171.
    1. Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007;25(5):548–554.
    1. Kakai H, Maskarinec G, Shumay DM, Tatsumura Y, Tasaki K. Ethnic differences in choices of health information by cancer patients using complementary and alternative medicine: an exploratory study with correspondence analysis. Soc Sci Med. 2003;56(4):851–862.
    1. Kimby CK, Launsø L, Henningsen I, Langgaard H. Choice of unconventional treatment by patients with cancer. J Altern Complement Med. 2003;9(4):549–561.
    1. Montbriand MJ. Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs. 1995;18(2):104–117.
    1. Oh HS, Park HA. Decision tree model of the treatment-seeking behaviors among Korean cancer patients. Cancer Nurs. 2004;27(4):259–266.
    1. Ohlén J, Balneaves LG, Bottorff JL, Brazier AS. The influence of significant others in complementary and alternative medicine decisions by cancer patients. Soc Sci Med. 2006;63(6):1625–1636.
    1. Ritvo P, Irvine J, Katz J, Matthew A, Sacamano J, Shaw BF. The patient's motivation in seeking complementary therapies. Patient Educ Couns. 1999;38(2):161–165.
    1. Verhoef MJ, Mulkins A, Carlson LE, Hilsden RJ, Kania A. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study. Integr Cancer Ther. 2007;6(4):345–353.
    1. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005;4(4):274–286.
    1. Verhoef MJ, White MA, Doll R. Cancer patients' expectations of the role of family physicians in communication about complementary therapies. Cancer Prev Control. 1999;3(3):181–187.
    1. White MA, Verhoef MJ, Davison BJ, Gunn H, Cooke K. Seeking mind, body and spirit healing—why some men with prostate cancer choose CAM (complementary and alternative medicine) over conventional cancer treatments. Integr Med Insights. 2008;3:1–11.
    1. White M, Verhoef M. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine. Integr Cancer Ther. 2006;5(2):117–122.
    1. White MA, Verhoef MJ. Decision-making control: why men decline treatment for prostate cancer. Integr Cancer Ther. 2003;2(3):217–224.
    1. Creswell JW. Research design: qualitative, quantitative, and mixed methods. 3rd ed. Thousand Oaks (CA): Sage Publications; 2009.
    1. Tobin GA, Begley C. Receiving bad news: a phenomenological exploration of the lived experience of receiving a cancer diagnosis. Cancer Nurs. 2008;31(5):E31–E39.
    1. Balneaves LG, Truant TL, Verhoef MJ, Ross B, Porcino AJ, Wong M, et al. The Complementary Medicine Education and Outcomes (CAMEO) program: a foundation for patient and health professional education and decision support programs. Patient Educ Couns. 2012;89(3):461–466.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться